| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 24042 | SPG-601 ( VSN-16R ) | 1246960-09-7 | ≧98.0% | ![]() |
| SPG-601(原名VSN-16R)是一种口服给药、同类首创的小分子药物,是 | ||||
| 24043 | AZD-5462 | 2787501-83-9 | ≧98.0% | ![]() |
| AZD5462 是 RXFP1 松弛素受体的小分子激动剂。 | ||||
| 24048 | Sebetralstat free base | 1933514-13-6 | 98% Min. | ![]() |
| Sebetralstat(KVD-900),一种口服血浆激肽释放酶抑制剂。 | ||||
| 24055 | Palupiprant ( E7046 ) | 1369489-71-3 | ≧98.0% | ![]() |
| E7046 is a potent and selective antagonist of the type 4 prostaglandin E2 (PGE2) rece | ||||
| 24015 | ASX-173 | 2748800-08-8 | ≧98.0% | ![]() |
| ASX-173 是一种抑制天冬酰胺合成酶 (ASNS) 活性的化合物。 | ||||
| 24057 | NDI-091143 | 2375840-87-0 | ≧97.0% | ![]() |
| NDI-091143 is a novel potent inhibitor of human ATP-citrate lyase, indirectly disrupt | ||||
| 24069 | Tuvusertib | 1613200-51-3 | ≧98.0% | ![]() |
| Tuvusertib, also known as M-1774 and ATR inhibitor 1, is a ATR inhibitor. M1774 selec | ||||
| 24066 | Lartesertib | 2495096-26-7 | 98% Min. | ![]() |
| Lartesertib(M4076)是丝氨酸/苏氨酸蛋白激酶ATM的强效抑制剂。 | ||||
| 24073 | Dabogratinib ( TYRA-300 ) | 2800223-30-5 | ≧98.0% | ![]() |
| Dabogratinib ( TYRA-300 )是一种口服选择性成纤维细胞生长因子受体3( | ||||
| 24083 | (Rac)-AF710B | 1235733-73-9 | ≧98.0% | ![]() |
| AF-710B 是 σ 和 M1 毒蕈碱受体的激动剂;AF710B 是 AF710 的对映体。 | ||||
| 24108 | JHU-083 | 1998725-11-3 | ≧98.0% | ![]() |
| JHU-083 选择性阻断大脑 CD11b+ 细胞中的谷氨酰胺酶活性,并防止慢 | ||||
| 24109 | CBR-5884 | 681159-27-3 | ≧98.0% | ![]() |
| CBR 5884 是一种磷酸甘油酸脱氢酶 (PHGDH) 抑制剂,能够抑制过度表达 | ||||
